GLI1-Altered Mesenchymal Tumor—Multiomic Characterization of a Case Series and Patient-Level Meta-analysis of One Hundred Sixty-Seven Cases for Risk Stratification

Authors: Yeung, Maximus C.F. ^{a, ∗}, Liu, Anthony P.Y. ^{b, c, d}, Wong, Sio-In ^e, Loong, Herbert H. ^{f, g}, Shek, Tony W.H. ^a

Source: In Modern Pathology January 2025 38(1)

Synergistic activities of Panobinostat and doxorubicin in soft tissue sarcomas

Authors: Zhang, Yingjun, Wong, C.H., Hui, Connie W.C., Tse, Teresa, Yeung, Vanessa, Cheung, Kingsley, Tao, Qian, Loong, Herbert H.

Source: In Biomedicine & Pharmacotherapy July 2024 176

NTRK gene fusion testing and management in lung cancer

Authors: Repetto, Matteo, Chiara Garassino, Marina, Loong, Herbert H., Lopez-Rios, Fernando, Mok, Tony, Peters, Solange, Planchard, David, Popat, Sanjay, Rudzinski, Erin R., Drilon, Alexander, Zhou, Caicun

Source: In Cancer Treatment Reviews June 2024 127

The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours

Authors: El Helali, Aya, Lam, Tai-Chung, Ko, Elaine Yee-Ling, Shih, David J.H., Chan, Chun Kau, Wong, Charlene H.L., Wong, Jason W.H., Cheung, Lydia W.T., Lau, Johnny K.S., Liu, Anthony P.Y., Chan, Ann S.Y., Loong, Herbert H., Lam, Stephen Tak Sum, Chan, Godfrey Chi-Fung, Lee, Victor H.F., Yuen, Kwok Keung, Ng, Wai-Tong, Lee, Anne W.M., Ma, Edmond S.K.

Source: In The Lancet Regional Health - Western Pacific July 2023 36

Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma

Authors: Bonvalot, Sylvie, Rutkowski, Piotr L., Thariat, Juliette, Carrère, Sébastien, Ducassou, Anne, Sunyach, Marie-Pierre, Agoston, Peter, Hong, Angela M., Mervoyer, Augustin, Rastrelli, Marco, Moreno, Victor, Li, Rubi K., Tiangco, Béatrice J., Herráez, Antonio Casado, Gronchi, Alessandro, Sy-Ortin, Teresa, Hohenberger, Peter, de Baère, Thierry, Cesne, Axel Le, Helfre, Sylvie, Saada-Bouzid, Esma, Anghel, Rodica M., Kantor, Guy, Montero, Angel, Loong, Herbert H., Vergés, Ramona, Kacso, Gabriel, Austen, Lyn, Servois, Vincent F., Wardelmann, Eva, Dimitriu, Mikaela, Said, Patricia, Lazar, Alexander J., Bovée, Judith V.M.G., Péchoux, Cécile Le, Pápai, Zsusanna

Source: International journal of radiation oncology, biology, physics. 114(3):422-432

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172887568.0x000001&indx=1&recIds=ETOCvdc_100172887568.0x000001

Local ablative radiotherapy on oligo‐progression while continued on epidermal growth factor receptor tyrosine kinase inhibitors in advanced non–small cell lung cancer patients: A longer cohort

Authors: Mok, Florence Siu ting, Tong, Macy, Loong, Herbert H., Mok, Tony S. K.

Source: Asia-Pacific journal of clinical oncology. 18(6):614-624

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100164957754.0x000001&indx=1&recIds=ETOCvdc_100164957754.0x000001

Clinical and Economic Impact of Upfront Next-Generation Sequencing for Metastatic NSCLC in East Asia

Authors: Loong, Herbert H., Wong, Carlos K.H., Chan, Catherine P.K., Chang, Andrea, Zhou, Zheng-Yi, Tang, Wenxi, Gibbs, Meaghan

Source: In JTO Clinical and Research Reports March 2022 3(3)

International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms

Authors: Giani, Claudia, Salawu, Abdulazeez, Ljevar, Silva, Denu, Ryan A., Napolitano, Andrea, Palmerini, Emanuela, Connolly, Elizabeth A., Ogura, Koichi, Wong, Daniel D., Scanferla, Roberto, Rosenbaum, Evan, Bajpai, Jyoti, Li, Zola Chia-Chen, Bae, Susie, D’Ambrosio, Lorenzo, Bialick, Steve, Wagner, Andrew J., Lee, Alexander T.J., Koseła-Paterczyk, Hanna, Baldi, Giacomo G., Brunello, Antonella, Lee, Yeh Chen, Loong, Herbert H., Boikos, Sosipatros, Campos, Fernando, Cicala, Carlo M., Maki, Robert G., Hindi, Nadia, Figura, Costanza, Almohsen, Shahd S., Patel, Sheyaskumar, Jones, Robin L., Ibrahim, Toni, Karim, Rooshdiya, Kawai, Akira, Carey-Smith, Richard, Boyle, Richard, Taverna, Silvia M., Lazar, Alexander J., Demicco, Elizabeth G., Bovee, Judith V.M.G., Dei Tos, Angelo P., Fletcher, Christopher, Baumhoer, Daniel, Sbaraglia, Marta, Schaefer, Inga-Marie, Miceli, Rosalba, Gronchi, Alessandro, Stacchiotti, Silvia

Source: The American Journal of Surgical Pathology; January 2025, Vol. 49 Issue: 1 p27-34, 8p

The treatment landscape of advanced angiosarcoma in Asia—A multi‐national collaboration from the Asian Sarcoma Consortium

Authors: Chen, Tom Wei‐Wu, Pang, Angela, Puhaindran, Mark E., Maw, Myo Myint, Loong, Herbert H., Sriuranpong, Virote, Chang, Chih‐Chi, Mingmalairak, Siyamol, Hirose, Takeshi, Endo, Makoto, Kawai, Akira, Farid, Mohamad, Tan, Sze Huey, Goh, Wei Lin, Quek, Richard, Chan, Jeffrey C. H., Leung, Alex K. C., Ngan, Roger K. C.

Source: Cancer science. 112(3):1095-1104

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100116434658.0x000001&indx=1&recIds=ETOCvdc_100116434658.0x000001

Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated RET positive non-small-cell lung cancer

Authors: Solomon, Benjamin J, Zhou, Cai Cun, Drilon, Alexander, Park, Keunchil, Wolf, Jürgen, Elamin, Yasir, Davis, Hannah M, Soldatenkova, Victoria, Sashegyi, Andreas, Lin, Aimee Bence, Lin, Boris K, F Loong, Herbert H, Novello, Silvia, Arriola, Edurne, Pérol, Maurice, Goto, Koichi, Santini, Fernando C

Source: Future oncology. 17(7):763-773

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187736412.0x000001&indx=1&recIds=ETOCvdc_100187736412.0x000001

An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor–Refractory ALK-Positive or ROS1-Positive NSCLC

Authors: Zhu, Viola W., Lin, Yen-Ting, Kim, Dong-Wan, Loong, Herbert H., Nagasaka, Misako, To, Hao, Ang, Yvonne Li-En, Ock, Chan-Young, Tchekmedyian, Nishan, Ou, Sai-Hong Ignatius, Syn, Nicholas L., Reungwetwattana, Thanyanan, Lin, Chia-Chi, Soo, Ross A.

Source: In Journal of Thoracic Oncology September 2020 15(9):1484-1496

Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non–Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study

Authors: Felip, Enriqueta, de Braud, Filippo G., Maur, Michela, Loong, Herbert H., Shaw, Alice Tsang, Vansteenkiste, Johan F., John, Thomas, Liu, Geoffrey, Lolkema, Martijn P., Selvaggi, Giovanni, Giannone, Vanessa, Cazorla, Pilar, Baum, Jason, Balbin, O. Alejandro, Wang, Luojun (Victor), Lau, Yvonne Y., Scott, Jeffrey W., Tan, Daniel Shao-Weng

Source: In Journal of Thoracic Oncology March 2020 15(3):392-403

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

Authors: Doebele, Robert C, Drilon, Alexander, Paz-Ares, Luis, Siena, Salvatore, Shaw, Alice T, Farago, Anna F, Blakely, Collin M, Seto, Takashi, Cho, Byung Chul, Tosi, Diego, Besse, Benjamin, Chawla, Sant P, Bazhenova, Lyudmila, Krauss, John C, Chae, Young Kwang, Barve, Minal, Garrido-Laguna, Ignacio, Liu, Stephen V, Conkling, Paul, John, Thomas, Fakih, Marwan, Sigal, Darren, Loong, Herbert H, Buchschacher, Gary L, Jr, Garrido, Pilar, Nieva, Jorge, Steuer, Conor, Overbeck, Tobias R, Bowles, Daniel W, Fox, Elizabeth, Riehl, Todd, Chow-Maneval, Edna, Simmons, Brian, Cui, Na, Johnson, Ann, Eng, Susan, Wilson, Timothy R, Demetri, George D ^*

Source: In The Lancet Oncology February 2020 21(2):271-282

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

Authors: Bonvalot, Sylvie, Rutkowski, Piotr L, Thariat, Juliette, Carrère, Sébastien, Ducassou, Anne, Sunyach, Marie-Pierre, Agoston, Peter, Hong, Angela, Mervoyer, Augustin, Rastrelli, Marco, Moreno, Victor, Li, Rubi K, Tiangco, Béatrice, Herraez, Antonio Casado, Gronchi, Alessandro, Mangel, László, Sy-Ortin, Teresa, Hohenberger, Peter, de Baère, Thierry, Le Cesne, Axel, Helfre, Sylvie, Saada-Bouzid, Esma, Borkowska, Aneta, Anghel, Rodica, Co, Ann, Gebhart, Michael, Kantor, Guy, Montero, Angel, Loong, Herbert H, Vergés, Ramona, Lapeire, Lore, Dema, Sorin, Kacso, Gabriel, Austen, Lyn, Moureau-Zabotto, Laurence, Servois, Vincent, Wardelmann, Eva, Terrier, Philippe, Lazar, Alexander J, Bovée, Judith V M G, Le Péchoux, Cécile, Papai, Zsusanna

Source: In The Lancet Oncology August 2019 20(8):1148-1159

Predictive biomarkers and tumor microenvironment in female genital melanomas: a multi-institutional study of 55 cases

Authors: Yu, Ying, Tse, Ka-Yu, Lee, Horace H. Y., Chow, Kin-Long, Tsang, Hing-Wai, Wong, Richard W. C., Cheung, Elaine T. Y., Cheuk, Wah, Lee, Victor W. K., Chan, Wai-Kong, Wong, Alice S. T., Loong, Herbert H. F., Chan, Karen K. L., Ngan, Hextan Y. S., Cheung, Annie N. Y., Ip, Philip P. C.

Source: Modern pathology. 33(1):138-152

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100193703001.0x000001&indx=1&recIds=ETOCvdc_100193703001.0x000001

Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong

Authors: Loong, Herbert H., Wong, Carlos K. H., Leung, Linda Kam Suet, Dhankhar, Praveen, Insinga, Ralph P., Chandwani, Sheenu, Hsu, Danny C., Lee, Mary Y. K., Huang, Min, Pellissier, James, Rai, Akanksha, Achra, Monika, Tan, Seng Chuen

Source: PharmacoEconomics - open. 4(2):235-247

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100174891785.0x000001&indx=1&recIds=ETOCvdc_100174891785.0x000001

Efficacy and safety of 1L selpercatinib in RET fusion-positive NSCLC: LIBRETTO-431 East Asian subgroup analysis.

Authors: Cheng, Ying, Loong, Herbert H., Zhou, Caicun, Nishino, Kazumi, Lee, Dae Ho, Lee, Se-Hoon, Yang, James Chih-Hsin, Liu, Dan, Rajakumar, Deborah, Han, Hongmei, Puri, Tarun, Lin, Aimee Bence, Goto, Koichi

Source: Journal of Clinical Oncology; 2024 Supplement, Vol. 42, p214-214, 24p

Effectiveness of using risk communication to help smokers with cancer quit smoking: A randomized controlled trial.

Authors: Li, William Ho Cheung, Lam, David Chi Leung, Sin, Kit Man, Wong, Eliza Lai Yi, Wong, Carlos K H, Loong, Herbert H., Cheung, Kai Yeung, Xia, Wei, Song, Peige, Chung, Joyce Oi Kwan

Source: Journal of Clinical Oncology; 2024 Supplement, Vol. 42, p158-158, 11p

Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non–Small-cell Lung Cancer in Asia

Authors: Loong, Herbert H., Raymond, Victoria M., Shiotsu, Yukimasa, Chua, Daniel T.T., Teo, Peter M.L., Yung, Tony, Skrzypczak, Stan, Lanman, Richard B., Mok, Tony S.K.

Source: In Clinical Lung Cancer September 2018 19(5):e601-e608

Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas

Authors: Loong, Herbert. H, Wong, Kwan-Hung, Tse, Teresa

Source: In ESMO Open 2018 3 Supplement 1